ASHLEY FULLER: Open Payments
NPI 1235514258 · CLINTON, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$894 in 48 payments from 16 companies in 2025. Trend: 2023 $295 · 2024 $579 · 2025 $894
Food & beverage: $894
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $284 |
| Lilly USA, LLC | 4 | $81 |
| AstraZeneca Pharmaceuticals LP | 4 | $74 |
| PFIZER INC. | 4 | $68 |
| Amgen Inc. | 4 | $68 |
| Dexcom, Inc. | 2 | $50 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $46 |
| Novo Nordisk Inc | 2 | $44 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $40 |
| Phathom Pharmaceuticals, Inc. | 3 | $40 |
Products named: VRAYLAR, JARDIANCE, MOUNJARO, BREZTRI, Dexcom G6 Transmitter, CAPLYTA, QULIPTA, VOQUEZNA.
Industry payments across IA — which companies pay providers there.
